Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, Amy S. Ruppert, Andrew J. Carroll, James W. Vardiman, Mark J. Pettenati, Maria R. Baer, Mazin B. Qumsiyeh, Prasad R. Koduru, Yi Ning, Robert J. Mayer, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield

Research output: Contribution to journalArticlepeer-review

262 Scopus citations

Fingerprint

Dive into the research topics of 'Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds